Pear Therapeutics, also referred to as Pear, is a company developing drug-software combination therapies to help people with mental and behavioral health issues. The company combines pharmaceutical therapy with software technology, such as digital applications and games. Pear has products at different stages of the development pipeline, including marketed products, across therapeutic areas, including mental health disorders, severe insomnia, and multiple sclerosis.
|HQ||Boston, MA, US||Map|
|Employees (est.) (Sept 2021)||247||(+3%)|
Pear Therapeutics total Funding
Pear Therapeutics latest funding size
Time since last funding
|10 months ago|
Pear Therapeutics investors
|Temasek Holdings, EDBI, Novartis, TrustBridge Partners, 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, Shanda Group, Bridge Builders Collaborative, Temasek, Jazz Partners, The Bridge Builders Collaborative, Blue Water Life Science Fund, QUAD Investment Management, SoftBank Vision Fund 2, CrimsoNox, Forth Management, Pilot House, Sarissa Capital|
Pear Therapeutics has 2.11k Twitter Followers. The number of followers has increased 1% month over month and increased 6.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Pear Therapeutics founded?
Pear Therapeutics was founded in 2013.
Who are Pear Therapeutics key executives?
Pear Therapeutics's key executives are Corey McCann, Chris Guiffre and Yuri Maricich.
How many employees does Pear Therapeutics have?
Pear Therapeutics has 247 employees.
Who are Pear Therapeutics competitors?
Competitors of Pear Therapeutics include Curalie, Hygieia and Jointfully.
Where is Pear Therapeutics headquarters?
Pear Therapeutics headquarters is located at 200 State St, Boston.
Where are Pear Therapeutics offices?
Pear Therapeutics has offices in Boston and San Francisco.
How many offices does Pear Therapeutics have?
Pear Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies